 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Associate, Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
Associate Professor, Departments of Community Health Sciences and Medicine, Faculty of Medicine, University of Calgary; Fellow, Institute of Health Economics, Edmonton, Alberta
Professor, Departments of Medicine, Clinical Neurosciences, and Community Health Sciences, Faculty of Medicine, University of Calgary
Reprints: Colleen J Maxwell PhD, Departments of Community Health Sciences and Medicine, Faculty of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB T2N 4N1, Canada, fax 403/270-7307, maxwell{at}ucalgary.ca
OBJECTIVE: To provide a comprehensive review of the literature on the measurement, correlates, and health outcomes of medication adherence among community-dwelling older adults.
DATA SOURCES: Searches of MEDLINE, PubMed, and International Pharmaceutical Abstracts databases for English-language literature (1966–December 2002) were conducted using one or more of the following terms: elderly, adherence/nonadherence, compliance/noncompliance, medication/drug, methodology/measurement, and hospitalization.
STUDY SELECTION AND DATA EXTRACTION: From the above search, studies of medication adherence in community-dwelling seniors were selected for review along with relevant publications from the reference lists of articles identified in the initial database search.
DATA SYNTHESIS: Although several methods are available for the assessment of adherence, accurate measurement continues to be difficult. The available evidence suggests that polypharmacy and poor patient–healthcare provider relationships (including the use of multiple providers) may be major determinants of nonadherence among older persons, with the impact of most sociodemographic factors being negligible. There is little consensus regarding other determinants of nonadherence. Relatively few high-quality investigations have examined the associations between nonadherence and subsequent health outcomes. Available data provide some support for increased health risks with nonadherence. However, interventions to improve adherence have seldom demonstrated positive effects on health outcomes.
CONCLUSIONS: There are few empirical data to support a simple systematic descriptor of the nonadherent patient. The inconsistencies across studies may be attributable, in part, to the inherent difficulties involved in the measurement of a behavioral risk factor such as nonadherence. Future research in this area would be strengthened by incorporation of detailed assessments of patient-reported reasons for nonadherence, the appropriateness of drug regimens, and the effect of nonadherence on health outcomes.
Key Words: adherence, compliance, elderly
Published Online, December 30, 2003. www.theannals.com, DOI 10.1345/aph.1D252
This article has been cited by other articles:
|
|
 |
|
  J. F. Steiner, P. M. Ho, B. L. Beaty, L. M. Dickinson, R. Hanratty, C. Zeng, H. M. Tavel, E. P. Havranek, A. J. Davidson, D. J. Magid, et al. Sociodemographic and Clinical Characteristics Are Not Clinically Useful Predictors of Refill Adherence in Patients With Hypertension Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sakthong, R. Chabunthom, and R. Charoenvisuthiwongs Psychometric Properties of the Thai Version of the 8-item Morisky Medication Adherence Scale in Patients with Type 2 Diabetes Ann. Pharmacother., May 1, 2009; 43(5): 950 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Pallares, E. R Powers, P. L Zwerner, A. Fowler, R. Reeves, and J. M Nappi Barriers to Clopidogrel Adherence Following Placement of Drug-Eluting Stents Ann. Pharmacother., February 1, 2009; 43(2): 259 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Elliott Non-adherence to medicines: not solved but solvable J Health Serv Res Policy, January 1, 2009; 14(1): 58 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Swanlund, K. A. Scherck, S. A. Metcalfe, and S. R. Jesek-Hale Keys to Successful Self-Management of Medications Nurs Sci Q, July 1, 2008; 21(3): 238 - 246. [Abstract] [PDF]
|
|
|
|
|
|
K. B Farris and B. B. Phillips Instruments Assessing Capacity to Manage Medications Ann. Pharmacother., July 1, 2008; 42(7): 1026 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Jackevicius, P. Li, and J. V. Tu Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction Circulation, February 26, 2008; 117(8): 1028 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-W. Tseng, E. F. Tierney, R. B. Gerzoff, R. A. Dudley, B. Waitzfelder, R. T. Ackermann, A. J. Karter, J. Piette, J. C. Crosson, Q. Ngo-Metzger, et al. Race/Ethnicity and Economic Differences in Cost-Related Medication Underuse Among Insured Adults With Diabetes: The Translating Research Into Action for Diabetes Study Diabetes Care, February 1, 2008; 31(2): 261 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Lee, K. A. Grace, and A. J. Taylor Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Controlled Trial JAMA, December 6, 2006; 296(21): 2563 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M Phatak and J. Thomas III Relationships Between Beliefs about Medications and Nonadherence to Prescribed Chronic Medications Ann. Pharmacother., October 1, 2006; 40(10): 1737 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Walker, M. Molitch, M. K. Kramer, S. Kahn, Y. Ma, S. Edelstein, K. Smith, M. K. Johnson, A. Kitabchi, J. Crandall, et al. Adherence to Preventive Medications: Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care, September 1, 2006; 29(9): 1997 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M Hess, M. A Raebel, D. A Conner, and D. C Malone Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures Ann. Pharmacother., July 1, 2006; 40(7): 1280 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Thule, A. G. Campbell, D. J. Kleinhenz, D. E. Olson, J. J. Boutwell, R. L. Sutliff, and C. M. Hart Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E114 - E122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Reisfield, G. D. Paulian, and G. R. Wilson "Johnny can't read": Another cause " of failed analgesia American Journal of Hospice and Palliative Medicine, November 1, 2005; 22(6): 433 - 436. [PDF]
|
|
|
|
 |
|
 J. George, D. C. M. Kong, R. Thoman, and K. Stewart Factors Associated With Medication Nonadherence in Patients With COPD Chest, November 1, 2005; 128(5): 3198 - 3204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Bailie, G. Eisele, L. Liu, E. Roys, M. Kiser, F. Finkelstein, R. Wolfe, F. Port, S. Burrows-Hudson, and R. Saran Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1110 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A Elliott, N. Barber, and R. Horne Cost-Effectiveness of Adherence-Enhancing Interventions: A Quality Assessment of the Evidence Ann. Pharmacother., March 1, 2005; 39(3): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
